D160N (p.Asp160Asn) variant of CLU (Clusterin)
D160N (p.Asp160Asn) in CLU (Clusterin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.45 / 1. The record also includes population frequency data and structural context.
D160N (p.Asp160Asn) variant details
- p.Asp160Asn
- NCI-TCGA TCGA novel
- Ensembl rs1800801175
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.447
- REVEL 0.21
- CADD 25.30
- PolyPhen-2 0.95
- SIFT 0.04
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available